BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 2, 2008
View Archived Issues
OBI-1 effective for bleeds in hemophilia A patients
Read More
FDA approves Concerta for ADHD in adults
Read More
Indevus receives FDA approvable letter for Nebido
Read More
Salix initiates phase III rifaximin trials in non-constipation IBS
Read More
Study data reported for panobinostat in hematological cancers
Read More
Snapshots: Vorinostat in hematological malignancies
Read More
Lowering of Alzheimer's dementia risk similar with different NSAID types
Read More
Anika Therapeutics announces commercial availability of Monovisc in Europe
Read More
New treatments for gastrointestinal disorders disclosed in recent patent literature
Read More
FDA approves Aciphex 20 mg for short-term treatment of GERD
Read More
FDA grants orphan drug designation for bupivacaine in postherpetic neuralgia
Read More
Health Canada grants marketing authorization to Basilea's Zeftera for cSSSI
Read More
ALT-1102 signifcantly reduces disease activity in RRMS in phase IIa study
Read More
Myriad Genetics to discontinue development of Flurizan following disappointing phase III results
Read More
Wyeth KK and Takeda launch new formulation of Enbrel for RA in Japan
Read More
Tripep reports preliminary results from phase I/II clinical study of ChronVac-C in HCV
Read More
Recent patents disclose novel agents for psychiatric conditions
Read More
SGX Pharmaceuticals submits IND application to the FDA for SGX-393 in CML
Read More
New anticancer agents imparted in recent patent literature
Read More
Introgen submits BLA to FDA and MAA to EMEA for Advexin in head and neck cancer
Read More
Novartis Pharma initiates phase I study of oral PTH-134 in postmenopausal osteoporosis
Read More
deCode reports positive results from pharmacology study of antiplatelet therapy DG-041
Read More
Novel DPP-IV inhibitor profiled at LG Life Sciences
Read More
Inhaled liposomal ciprofloxacin reduces bacterial infection, improves lung function in CF study
Read More
NanoViricides to initiate animal efficacy studies of EKC-Cide in Japan
Read More
Synthetic Blood International changes name to Oxygen Biotherapeutics
Read More
VioQuest submits 510(k) application to FDA for Xyfid for skin disorders
Read More